Clinical Trial Update: Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

View source ↗

Summary

The clinical trial update reports that the study on spontaneous regression in metastatic melanoma and renal cell carcinoma remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Renal Cell Carcinoma

Snippet

Sponsor: Indiana University | Conditions: Melanoma; Renal Cell Carcinoma | Status: ACTIVE_NOT_RECRUITING